Rocklatan is a brand-name prescription eye drop used to treat open-angle glaucoma and ocular hypertension. It is available in a 2.5 ml size [1].
What is the active ingredient in Rocklatan?
The active ingredient in Rocklatan is netarsudil ophthalmic solution, 0.02% [1].
How does Rocklatan work to lower eye pressure?
Rocklatan works by increasing the outflow of fluid from the eye, which helps to reduce intraocular pressure (IOP) [1]. It is a rho kinase inhibitor, a class of drugs that target a specific pathway involved in aqueous humor outflow [2].
How is Rocklatan administered?
Rocklatan is administered as one drop to the affected eye(s) once daily [1].
What are the common side effects of Rocklatan?
Common side effects reported with Rocklatan include conjunctival hyperemia (redness of the eye), corneal verticillata (a type of corneal deposit), instillation site pain, and blurred vision [1].
How does Rocklatan compare to other glaucoma eye drops?
Rocklatan is a once-daily medication, which may offer a dosing convenience compared to some other glaucoma treatments that require multiple daily doses. Its mechanism of action as a rho kinase inhibitor is distinct from other common classes of glaucoma medications like prostaglandin analogs, beta-blockers, or alpha-agonists [2].
When does Rocklatan's patent expire?
Information on the specific patent expiry dates for Rocklatan can be found on patent tracking resources like DrugPatentWatch.com [3]. Understanding patent exclusivity is crucial for determining when generic or biosimilar versions might become available.
Who manufactures Rocklatan?
Rocklatan is manufactured by Lannett Company, Inc. [1].